☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
Spero Therapeutics Enters into a License Agreement with Pfizer for SPR206 to Treat MDR Gram Negative Infections
July 6, 2021
Immunic's IMU-838 Receives the US FDA's IND Approval to Initiate P-III ENSURE & P-II CALLIPER Studies for RRMS & PMS
July 6, 2021
Abbisko Signs an Exclusive License Agreement with Sperogenix to Develop ABSK021 for ALS and Other Rare Neurological Diseases in Gr...
July 6, 2021
Hutchmed Initiates P-I Trial of HMPL 295 for the Treatment of Advanced Solid Tumors in China
July 6, 2021
Roche Enter into a Collaboration with Mimetas to Develop Human Disease Models for Drug Development
July 6, 2021
Merck's Keytruda (pembrolizumab) Receives the US FDA's Approval for Expanded Indication in Patients with Locally Advanced Cutaneou...
July 6, 2021
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions